Mark L. Gonzalgo

University of Miami — United States

Medicine · Health Sciences

50h-index8.6kcitations424works1.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bladder and Urothelial Cancer Treatments(171), Prostate Cancer Diagnosis and Treatment(108), Renal cell carcinoma treatment(85), Urinary and Genital Oncology Studies(80), Prostate Cancer Treatment and Research(75)

Publications424 total

Prediction Analysis of Microarray of 50 genes (PAM50) classifier validated for predicting prostate cancer progression in active surveillance: Miami Active Surveillance Trial (MAST).
PubMed·2026
MRI-based patient selection for active surveillance in prostate cancer using U-Found: a generalized deep learning model
Cancer Imaging·2026Open Access
Thinking, Feeling, Choosing: The Affective Architecture of Low to Intermediate Risk Prostate Cancer Treatment Decision Making
2026Open Access
Elevated creatinine-to-hemoglobin ratio is a novel preoperative marker for worsened survival outcomes in upper tract urothelial carcinoma: analysis from the ROBUUST registry
Minerva Urology and Nephrology·2025
Neoadjuvant versus adjuvant chemotherapy for upper tract urothelial carcinoma in the setting of clinical node positive disease: analysis of the ROBUUST registry
World Journal of Urology·2025
4K density: Adjusting the 4Kscore for prostate volume to improve risk stratification of clinically significant prostate cancer in men undergoing prostate biopsy
Prostate Cancer and Prostatic Diseases·2025
Utilization of intravesical chemotherapy following TURBT: A pre-implementation analysis of American College of Surgeon Commission on Cancer GU quality measures
Urologic Oncology Seminars and Original Investigations·2025
Prolonged Progression-Free Survival, Disease-Free Survival, and Cystectomy Avoidance With IL-15 Receptor Lymphocyte–Stimulating Agent NAI Plus Bacillus Calmette-Guérin in Bacillus Calmette-Guérin–Unresponsive Papillary-Only Nonmuscle-Invasive Bladder Cancer
The Journal of Urology·2025· 2 citedOpen Access
Editorial Comment
The Journal of Urology·2025
Radical nephroureterectomy vs kidney sparing surgery for upper tract urothelial carcinoma in solitary kidney patients: a multi-institutional analysis of the ROBUUST 2.0 registry
World Journal of Urology·2025· 3 citedOpen Access
Prognostic Impact of Adjuvant Immunotherapy in Patients with High-Risk Upper Tract Urothelial Cancer: Results from the ROBUUST 2.0 Collaborative Group
Cancers·2025Open Access
Can Genomic Classifiers in Biopsy Cores With Grade Group 1 Cancer Predict Higher-Grade Disease Elsewhere in the Prostate? Results From the Prospective Miami Active Surveillance Trial
The Journal of Urology·2025Open Access
New Insights into Upper Tract Urothelial Carcinoma: Lessons Learned from the ROBUUST Collaborative Study
Cancers·2025· 2 citedOpen Access
A prospective analysis of ureteral stenting during radical cystectomy and ileal conduit urinary diversion: Paediatric feeding tubes versus single‐J stents
BJUI Compass·2025Open Access
Combined neoadjuvant and adjuvant therapy versus adjuvant therapy in high-risk upper tract urothelial carcinoma: a propensity matched multicenter analysis (ROBUUST 2.0 International Collaborative Group)
World Journal of Urology·2025
MP33-10 LEVERAGING AUGMENTED REALITY TO ELEVATE PATIENT UNDERSTANDING AND SATISFACTION WITH RENAL MASS IMAGING: INSIGHTS FROM A PROSPECTIVE STUDY
The Journal of Urology·2025
MP06-03 SURGICAL INTELLIGENCE AND LARGE LANGUAGE MODELS: LEVERAGING AI FOR COMPLETE AND ACCURATE OPERATIVE REPORTING
The Journal of Urology·2025
PD18-06 RACIAL AND ETHNIC DISPARITIES IN THE UTILIZATION OF MINIMALLY INVASIVE AND NEPHRON-SPARING SURGERIES FOR RENAL CELL CARCINOMA
The Journal of Urology·2025
MP10-06 VALIDATION OF PAM50 AND PSC GENOMIC CLASSIFIER SYSTEMS FOR PREDICTING PROSTATE CANCER PROGRESSION IN ACTIVE SURVEILLANCE: RESULTS FROM THE MIAMI MAST PROSPECTIVE CLINICAL TRIAL
The Journal of Urology·2025
IP12-20 VALIDATION OF THE AUA CLINICAL RISK CATEGORIES FOR NON-METASTATIC UPPER TRACT UROTHELIAL CARCINOMA: ANALYSIS OF THE ROBUUST 3.0 REGISTRY
The Journal of Urology·2025
page 1 of 22Next →

Frequent Co-authors

Peter A. Jones(10), William G. Nelson(6), Dipen J. Parekh(5), Angelo M. De Marzo(5), Christian P. Pavlovich(5), Bruce J. Trock(5), Elizabeth B. Humphreys(5), Sam S. Chang(4), Nachiketh Soodana‐Prakash(4), Gangning Liang(4), Ahmed Magheli(4), Alan W. Partin(4), Erik P. Castle(3), Michael Woods(3), Robert S. Svatek(3), Alon Z. Weizer(3), Badrinath R. Konety(3), Tracey L. Krupski(3), Norm D. Smith(3), Ahmad Shabsigh(3)